Skip to main content
Log in

Implementing Dried Blood Spot Sampling for Clinical Pharmacokinetic Determinations: Considerations from the IQ Consortium Microsampling Working Group

  • Editorial
  • Published:
The AAPS Journal Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig 7

References

  1. Rahavendran SV, Vekich S, Skor H, Batugo M, Nguyen L, Shetty B, et al. Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS. Bioanalysis. 2012;4(9):1077–95.

    Article  CAS  PubMed  Google Scholar 

  2. Beaudette P, Bateman KP. Discovery stage pharmacokinetics using dried blood spots. J Chromatogr B Anal Technol Biomed Life Sci. 2004;809(1):153–8.

    Article  CAS  Google Scholar 

  3. Barfield M, Spooner N, Lad R, Parry S, Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. J Chromatogr B. 2008;870(1):32–7.

    Article  CAS  Google Scholar 

  4. Spooner N, Ramakrishnan Y, Barfield M, Dewit O, Miller S. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. Bioanalysis. 2010;2(8):1515–22.

    Article  CAS  PubMed  Google Scholar 

  5. http://www.cdc.gov/labstandards/pdf/vitaleqa/Poster_PreparingDBS.pdf

  6. D’Arienzo C, Ji Q, Discenza L, Cornelius G, Hynes J, Cornelius L, et al. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis. 2010;2(8):1415–22.

    Article  PubMed  Google Scholar 

  7. Bowen CL, Volpatti J, Cades X, Licea-Perez H, Evans CA. Evaluation of glucuronide metabolite stability in dried blood spots. Bioanalysis. 2012;4(23):2823–32.

    Article  CAS  PubMed  Google Scholar 

  8. Personal communications from authors Pat Zane and Chris James

  9. Liu G, Ji QC, Jemal M, Tymiak AA, Arnold ME. Approach to evaluating dried blood spot sample stability during drying process and discovery of a treated card to maintain analyte stability by rapid on-card pH Modification. Anal Chem. 2011;83(23):9033–8.

    Article  CAS  PubMed  Google Scholar 

  10. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338–43.

    CAS  PubMed  Google Scholar 

  11. Edelbroek PM, Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit. 2009;31(3):327–36.

    Article  PubMed  Google Scholar 

  12. Solomon SS, Solomon S, Rodriguez II, McGarvey ST, Ganesh AK, Thyagarajan SP, et al. Dried blood spots (DBS): a valuable tool for HIV surveillance in developing/tropical countries. Int J STD AIDS. 2002;13:25–8.

    Article  PubMed  Google Scholar 

  13. Dainty TC, Richmond ES, Davies I, Blackwell MP. Dried blood spot bioanalysis: an evaluation of techniques and opportunities for reduction and refinement in mouse and juvenile rat toxicokinetic studies. Int J Toxicol. 2012;31(1):4–13.

    Article  CAS  PubMed  Google Scholar 

  14. Festing S, Wilkinson R. The ethics of animal research. Eur Mol Biol Organ Rep. 2007;8:526–30.

    CAS  Google Scholar 

  15. Dainty TC, Richmond ES, Davies I, Blackwell MP. Dried blood spot bioanalysis: an evaluation of techniques and opportunities for reduction and refinement in mouse and juvenile rat toxicokinetic studies. Int J Toxicol. 2012;31(1):4–13.

    Article  CAS  PubMed  Google Scholar 

  16. Zisowsky J, Krause A, Dingemanse J. Drug development for pediatric populations: regulatory aspects. Pharm. 2010;2(4):364–88.

    Google Scholar 

  17. Beharry M. DBS: a UK (MHRA) regulatory perspective. Bioanalysis. 2012;2(8):1363–4.

    Article  Google Scholar 

  18. Viswanathan CT. Perspectives on microsampling: DBS. Bioanalysis. 2012;4(12):1417–9.

    Article  CAS  PubMed  Google Scholar 

  19. Viswanathan CT. Regulatory Perspectives on Dried Blood Spots. 12th Annual Land O’Lakes Bioanalytical Conference; Agency and Industry Perspectives on Biomarkers, Bloodspots and Beyond, Merrimac, WI, July 2011.

  20. Timmerman P, White S, Cobb Z, de Vries R, Thomas E, van Baar B. Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium. 2013; 5(17): 2129–2136.

  21. Abbott R, Smeraglia J, White S, Luedtke S, Brunet L, Thomas E, Globig S, and Timmerman P. Conference Report: Connecting strategies on dried blood spots. 2010; Bioanalysis: 2 (11) 1809–1816

  22. Evans CA, Bruce C, Emmons GT, Gallenberg L, Ji QC, Kinter L, et al. DIA/PhRMA workshop on dried blood spot sampling in the pharmaceutical industry: methodology, implementation and best practices. Bioanalysis. 2010;2(8):1355–9.

    Article  CAS  PubMed  Google Scholar 

  23. Kehler JR, Bowen CL, Boram SL, Evans CA. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS. Bioanalysis. 2010;2(8):1461–8.

    Article  CAS  PubMed  Google Scholar 

  24. Li W, Tse FL. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed Chromatogr. 2010;24(1):49–65.

    Article  PubMed  Google Scholar 

  25. Zane P, Emmons G. Microsampling in Pharmaceutical Bioanalysis. Online eBook Chapter. Future Science; 2013.

  26. O’Mara M, Hudson-Curtis B, Olson K, Yueh Y, Dunn J, Spooner N. The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis. 2011;3(2):2335–47.

    Article  PubMed  Google Scholar 

  27. Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative analysis of drugs. Bioanalysis. 2010;2(8):1385–95.

    Article  CAS  PubMed  Google Scholar 

  28. de Vries R, Barfield M, van de Merbel N, Schmid B, Siethoff C, Ortiz J, et al. The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium. Bioanalysis. 2013;5(17):2147–60.

    Article  PubMed  Google Scholar 

  29. Fan LM, Lee JA. Managing the effect of hematocrit on DBS analysis in a regulated environment. Bioanalysis. 2012;4(4):345–7.

    Article  CAS  PubMed  Google Scholar 

  30. Meesters RJW, Zhang J, van Huizen NA, Hooff GP, Gruters RA, Luider TM. Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis. Bioanalysis. 2012;4(16):2027–35.

    Article  CAS  PubMed  Google Scholar 

  31. Li FM, Zulkoski J, Fast D, Michael S. Perforated dried blood spots: a novel format for accurate microsampling. Bioanalysis. 2011;3(20):2321–33.

    Article  CAS  PubMed  Google Scholar 

  32. Xu Y, Woolf E, Agrawal NGB, Kothare P, Pucci V, Bateman KP. Merck’s perspective on the implementation of dried blood spot technology in clinical drug development—what, when and how. Bioanalysis. 2013;5(3):341–50.

    Article  CAS  PubMed  Google Scholar 

  33. Emmons G, Rowland M. Pharmacokinetic considerations as to when to use dried blood spot sampling. Bioanalysis. 2010;2(11):1791–6.

    Article  CAS  PubMed  Google Scholar 

  34. Emmons G, Rowland M. Use of dried blood spots in drug development: pharmacokinetic considerations. AAPS J. 2010;12(3):290–3.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Wickremsinhe ER, Huang NH, Abdul BG, Knott K, Ruterbories KJ, Manro JR. Preclinical bridging studies: understanding dried blood spot and plasma exposure profiles. Bioanalysis. 2013;5(2):159–70.

    Article  CAS  PubMed  Google Scholar 

  36. Chiou WL. The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics. Clin Pharmacokinet. 1989;17(3):175–99.

    Article  CAS  PubMed  Google Scholar 

  37. Timmerman P. Tiered approach revisited: introducing stage-appropriate or assay-appropriate scientific validation. Bioanalysis. 2014;6(5):599–604.

    Article  CAS  PubMed  Google Scholar 

  38. Denniff P, Spooner N. Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal Chem. 2014;86(16):8489–95.

    Article  CAS  PubMed  Google Scholar 

  39. Chapman C, Chivers S, Gliddon D, Mitchell D, Robinson S, Sangster T, Sparrow S, Spooner N, Wilson A. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. Drug Discovery Today. 2014 (in press)

  40. Kim JH, Woenker T, Adamec J, Regnier FE. Simple, miniaturized blood plasma extraction method. Anal Chem. 2013;85(23):11501–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher Evans.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Evans, C., Arnold, M., Bryan, P. et al. Implementing Dried Blood Spot Sampling for Clinical Pharmacokinetic Determinations: Considerations from the IQ Consortium Microsampling Working Group. AAPS J 17, 292–300 (2015). https://doi.org/10.1208/s12248-014-9695-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12248-014-9695-3

Navigation